Karberg Katherine A
Bayer Crop Science, Chesterfield, MO, United States.
Front Bioeng Biotechnol. 2025 Jun 23;13:1620652. doi: 10.3389/fbioe.2025.1620652. eCollection 2025.
Risk assessment frameworks for plant agricultural biotechnology products have been in place for decades, focused on the evaluation of living biotechnology products created through genetic engineering. These products contain genetic material from outside the breeder's gene pool, which is often from different taxa or represents "novel combinations of genetic material". These products are typically considered to be "genetically modified" (GM) organisms in regulatory jurisdictions. However, in the microbial world, particularly among Bacteria and Archaea, the rapid expansion of genome sequence databases shows that natural microbial innovation primarily occurs through the natural exchange of genetic material from various sources, even from different taxa. This means that many microbes can be considered naturally occurring GM organisms. This raises the question of whether labeling a microbe as GM is always scientifically relevant for risk assessment. In most regulatory frameworks, being classified as GM significantly impacts the registration path, especially for microbes intended for environmental release. A more effective and science-based regulatory approach would assess the actual functions of a microbe rather than relying on the uncertain classification of its genetic material. This would benefit regulators, developers, and society by promoting the use of microbial technologies for agricultural use.
植物农业生物技术产品的风险评估框架已经存在了几十年,重点是对通过基因工程创造的活体生物技术产品进行评估。这些产品包含育种者基因库之外的遗传物质,这些遗传物质通常来自不同的分类群,或者代表“遗传物质的新组合”。在监管辖区,这些产品通常被视为“转基因”(GM)生物。然而,在微生物世界中,特别是在细菌和古细菌中,基因组序列数据库的迅速扩展表明,天然微生物创新主要通过来自各种来源,甚至来自不同分类群的遗传物质的自然交换而发生。这意味着许多微生物可以被视为天然存在的转基因生物。这就提出了一个问题,即对一种微生物进行转基因标记是否在科学上总是与风险评估相关。在大多数监管框架中,被归类为转基因对注册途径有重大影响,特别是对于打算释放到环境中的微生物。一种更有效且基于科学的监管方法将评估微生物的实际功能,而不是依赖于其遗传物质的不确定分类。这将通过促进微生物技术在农业中的应用,使监管机构、开发者和社会受益。